Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy

Hongqing Zhuang; Hailing Hou; Zhiyong Yuan; Jun Wang; Qingsong Pang; Lujun Zhao; Ping Wang
May 2014
OncoTargets & Therapy;2014, Vol. 7, p807
Academic Journal
Purpose: The aim of this study was to investigate radiation pneumonitis and its associated risk factors in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy. Materials and methods: We conducted an analysis of patients with nonoperable stage IIIA-IV non-small-cell lung cancer who were treated with concurrent thoracic radiotherapy and erlotinib (ClinicalTrials.gov identifier: NCT00973310). The Common Terminology Criteria for Adverse Events version 3.0 grading system was applied to evaluate the incidence of radiation pneumonitis. The lung dosimetric parameters were recorded in accordance with the treatment plan, and the study endpoint was radiation pneumonitis at grade 2 or more. Results: Among the 24 selected clinical cases, nine were identified with radiation pneumonitis of grade 2 or above (37.5%). This included four cases with grade 2 (16.7%), two cases with grade 3 (8.3%), and three cases with grade 5 (12.5%). The results showed that the planning target volume was a significant factor affecting the incidence of radiation pneumonitis. All lung dosimetric parameters exhibited statistically significant differences between patients with pneumonitis and patients without pneumonitis. The receiver operating characteristic (ROC) curve analysis showed that all lung dosimetric parameters were useful in predicting the incidence of radiation pneumonitis. In addition, the threshold values of V5, V10, V15, V20, V30, and mean lung dose were .44%, .29%, .27%, .22%, .17% and .1,027 cGy, respectively. Conclusion: Special attention should be paid to the adverse effects of radiation pneumonitis in concurrent thoracic radiotherapy and erlotinib treatment. Lung dosimetric parameters are important predictive factors in radiation pneumonitis.


Related Articles

  • Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Early Stage Non-small Cell Lung Cancer. Lu CHEN; Yaqin ZHAO; Feng XU // Chinese Journal of Lung Cancer;2014, Vol. 17 Issue 4, p351 

    With the development of radiation technology, stereotactic body radiation therapy (SBRT) has been widely used in early stage non-small cell lung cancer (NSCLC). It is not only the standard therapy for medically inoperable early-stage NSCLC, but also one of the therapies for operable early-stage...

  • Predictors of radiation pneumonitis and pulmonary function changes after concurrent chemoradiotherapy of non-small cell lung cancer. Young Hee Park; Jae-Sung Kim // Radiation Oncology Journal;Mar2013, Vol. 31 Issue 1, p34 

    Purpose: To evaluate the predictive factors of radiation pneumonitis (RP) and associated changes in pulmonary function after definitive concurrent chemoradiotherapy (CCRT) in patients with non-small cell lung cancer (NSCLC). Materials and Methods: Medical records of 60 patients with NSCLC who...

  • Bioinformatics Methods for Learning Radiation-Induced Lung Inflammation from Heterogeneous Retrospective and Prospective Data. Spencer, Sarah J.; Bonnin, Damian Almiron; Deasy, Joseph O.; Bradley, Jeffrey D.; El Naqa, Issam // Journal of Biomedicine & Biotechnology;2009 Regular Issue, p1 

    Radiotherapy outcomes are determined by complex interactions between physical and biological factors, reflecting both treatment conditions and underlying genetics. Recent advances in radiotherapy and biotechnology provide new opportunities and challenges for predicting radiation-induced...

  • Patients with severe emphysema have a low risk of radiation pneumonitis following stereotactic body radiotherapy. ISHIJIMA, M.; NAKAYAMA, H.; ITONAGA, T.; TAJIMA, Y.; SHIRAISHI, S.; OKUBO, M.; MIKAMI, R.; TOKUUYE, K. // British Journal of Radiology;Feb2015, Vol. 88 Issue 1046, p1 

    Objective: To evaluate the risk of radiation pneumonitis (RP) after stereotactic radiotherapy (SBRT) for patients presenting with severe pulmonary emphysema. Methods: This study included 40 patients with Stage I non-small-cell lung cancer who underwent SBRT, 75 Gy given in 30 fractions, at the...

  • Erlotinib.  // Reactions Weekly;3/5/2011, Issue 1341, p17 

    The article describes the case of a 77-year-old man who developed radiation pneumonitis while receiving treatment with erlotinib and radiotherapy for non-small cell lung cancer.

  • Hospital-associated pneumonia risk increased with use of acid-suppressive medications.  // Infectious Disease News;Jul2009, Vol. 22 Issue 7, p25 

    The article discusses a study which examined the relationship between hospital-associated pneumonia and acid-suppressive medications in Boston, Massachusetts.

  • Incidence of pneumonia and risk factors among patients with head and neck cancer undergoing radiotherapy. Chin-Nan Chu; Chih-Hsin Muo; Shang-Wen Chen; Shu-Yu Lyu; Morisky, Donald E. // BMC Cancer;2013, Vol. 13 Issue 1, p1 

    Background: This study investigated the incidence and patient- and treatment-related risk factors related to pneumonia acquired during radiotherapy (PNRT) in head and neck cancer (HNC) patients. Methods: Using the universal insurance claims data, 15,894 total HNC patients between 1998 and 2007...

  • Hospitalization for Pneumonia and Risk of Cardiovascular Disease. Violi, Francesco; Cangemi, Roberto; Calvieri, Camilla // JAMA: Journal of the American Medical Association;5/5/2015, Vol. 313 Issue 17, p1753 

    A letter to the editor is presented in response to the article "Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease" by Vicente F. Corrales-Medina, Karina N. Alvarez, Lisa A. Weissfeld and others in the January 20, 2015, issue.

  • Hospitalization for Pneumonia and Risk of Cardiovascular Disease. Corrales-Medina, Vicente F.; Alvarez, Karina N.; Yende, Sachin // JAMA: Journal of the American Medical Association;5/5/2015, Vol. 313 Issue 17, p1753 

    A reply from the authors is presented to a letter to the editor from Francesco Violi, Roberto Cangemi, and Camilla Calvieri in the current issue responding to their article "Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease."


Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics